In Silico Methods for Development of Generic Drug–Device Combination Orally Inhaled Drug Products-Reference-Cited by-同舟云学术

In Silico Methods for Development of Generic Drug–Device Combination Orally Inhaled Drug Products

Published:2019-05-21 Issue:6 Volume:8 Page:359-370
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Walenga Ross L.¹,Babiskin Andrew H.¹,Zhao Liang¹

Affiliation:

1. Division of Quantitative Methods and ModelingOffice of Research and StandardsOffice of Generic DrugsCenter for Drug Evaluation and ResearchUS Food and Drug Administration Silver Spring Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12413

Reference99 articles.

1. Association for Accessible Medicines.Generic Drug Access & Savings in the U.S. (2018). Accessed November 17 2018.

2. Center for Disease Control.Asthma (2018). Accessed November 17 2018.

3. Center for Disease Control.Chronic Obstructive Pulmonary Disease (2018). Accessed November 17 2018.

4. Tertiary patenting on drug–device combination products in the United States

5. Bioequivalence for Orally Inhaled and Nasal Drug Products

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Critical Analysis of the CFD-DEM Simulation of Pharmaceutical Aerosols Deposition in Upper Intra-Thoracic Airways: Considerations on Aerosol Transport and Deposition;Pharmaceutics;2024-08-24

2. Model‐informed Drug Development ( MIDD ) Regarding Regulatory Requirements and Thinking;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

3. Artificial Intelligence and Computational Modeling in Orally Inhaled Drugs;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

4. İLAÇLARDA SANAL BİYOEŞDEĞERLİK UYGULAMALARI;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-06-14

5. Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023;The AAPS Journal;2024-04-24